Pancreatic adenocarcinoma

Margaret Tempero; Rameezs Alasadi; J. Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B. Benson; Pankaj Bhargava; John L. Cameron; Ephraim S. Casper; John P. Hoffman; Paula Kim; Wui Jin Koh; Boris Kuvshinoff; Mokenge P. Malafa; Peter Muscarella; Eric K. Nakakura; Aaron R. Sasson; Stephen Shibata; Dennis C. Shrieve; Mark Talamonti; Douglas S. Tyler; Hanlin Wang; Robert S. Warren; Christopher Willett; Robert A. Wolff

doi:10.6004/jnccn.2007.0085

Pancreatic adenocarcinoma

Margaret Tempero
, Rameezs Alasadi
, J. Pablo Arnoletti
, Stephen Behrman
, Edgar Ben-Josef
, Al B. Benson
, Pankaj Bhargava
, John L. Cameron
, Ephraim S. Casper
, John P. Hoffman
, Paula Kim
, Wui Jin Koh
, Boris Kuvshinoff
, Mokenge P. Malafa
, Peter Muscarella
, Eric K. Nakakura
, Aaron R. Sasson
, Stephen Shibata
, Dennis C. Shrieve
, Mark Talamonti

Douglas S. Tyler, Hanlin Wang, Robert S. Warren, Christopher Willett, Robert A. Wolff

Surgery

University of California at San Francisco
Northwestern University
University of Alabama at Birmingham
University of Tennessee Cancer Institute
University of Michigan, Ann Arbor
Massachusetts General Hospital Cancer Center
Johns Hopkins University
Memorial Sloan-Kettering Cancer Center
Fox Chase Cancer Center
Translating Research Across Communities (TRAC)
Seattle Cancer Care Alliance
Roswell Park Cancer Institute
Moffitt Cancer Center
Ohio State University
City of Hope National Med Center
University of Utah
Duke University
Washington University St. Louis
University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

Original language	English
Pages (from-to)	998-1033
Number of pages	36
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	5
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2007.0085
State	Published - Nov 2007

Keywords

Adenocarcinoma
Ductal carcinoma
Endoscopic retrograde cholangiopancreatography
Gemcitabine
NCCN clinical practice guidelines
Pancreas
Ultrasonography

Access to Document

10.6004/jnccn.2007.0085

Cite this

Tempero, M., Alasadi, R., Arnoletti, J. P., Behrman, S., Ben-Josef, E., Benson, A. B., Bhargava, P., Cameron, J. L., Casper, E. S., Hoffman, J. P., Kim, P., Koh, W. J., Kuvshinoff, B., Malafa, M. P., Muscarella, P., Nakakura, E. K., Sasson, A. R., Shibata, S., Shrieve, D. C., ... Wolff, R. A. (2007). Pancreatic adenocarcinoma. JNCCN Journal of the National Comprehensive Cancer Network, 5(10), 998-1033. https://doi.org/10.6004/jnccn.2007.0085

@article{ff65ffbf2b61456a9a4438793e14cd81,

title = "Pancreatic adenocarcinoma",

abstract = "Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.",

keywords = "Adenocarcinoma, Ductal carcinoma, Endoscopic retrograde cholangiopancreatography, Gemcitabine, NCCN clinical practice guidelines, Pancreas, Ultrasonography",

author = "Margaret Tempero and Rameezs Alasadi and Arnoletti, \{J. Pablo\} and Stephen Behrman and Edgar Ben-Josef and Benson, \{Al B.\} and Pankaj Bhargava and Cameron, \{John L.\} and Casper, \{Ephraim S.\} and Hoffman, \{John P.\} and Paula Kim and Koh, \{Wui Jin\} and Boris Kuvshinoff and Malafa, \{Mokenge P.\} and Peter Muscarella and Nakakura, \{Eric K.\} and Sasson, \{Aaron R.\} and Stephen Shibata and Shrieve, \{Dennis C.\} and Mark Talamonti and Tyler, \{Douglas S.\} and Hanlin Wang and Warren, \{Robert S.\} and Christopher Willett and Wolff, \{Robert A.\}",

year = "2007",

month = nov,

doi = "10.6004/jnccn.2007.0085",

language = "English",

volume = "5",

pages = "998--1033",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "10",

}

Tempero, M, Alasadi, R, Arnoletti, JP, Behrman, S, Ben-Josef, E, Benson, AB, Bhargava, P, Cameron, JL, Casper, ES, Hoffman, JP, Kim, P, Koh, WJ, Kuvshinoff, B, Malafa, MP, Muscarella, P, Nakakura, EK, Sasson, AR, Shibata, S, Shrieve, DC, Talamonti, M, Tyler, DS, Wang, H, Warren, RS, Willett, C & Wolff, RA 2007, 'Pancreatic adenocarcinoma', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 10, pp. 998-1033. https://doi.org/10.6004/jnccn.2007.0085

TY - JOUR

T1 - Pancreatic adenocarcinoma

AU - Tempero, Margaret

AU - Alasadi, Rameezs

AU - Arnoletti, J. Pablo

AU - Behrman, Stephen

AU - Ben-Josef, Edgar

AU - Benson, Al B.

AU - Bhargava, Pankaj

AU - Cameron, John L.

AU - Casper, Ephraim S.

AU - Hoffman, John P.

AU - Kim, Paula

AU - Koh, Wui Jin

AU - Kuvshinoff, Boris

AU - Malafa, Mokenge P.

AU - Muscarella, Peter

AU - Nakakura, Eric K.

AU - Sasson, Aaron R.

AU - Shibata, Stephen

AU - Shrieve, Dennis C.

AU - Talamonti, Mark

AU - Tyler, Douglas S.

AU - Wang, Hanlin

AU - Warren, Robert S.

AU - Willett, Christopher

AU - Wolff, Robert A.

PY - 2007/11

Y1 - 2007/11

N2 - Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

AB - Overall, in view of the poor outcome of patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

KW - Adenocarcinoma

KW - Ductal carcinoma

KW - Endoscopic retrograde cholangiopancreatography

KW - Gemcitabine

KW - NCCN clinical practice guidelines

KW - Pancreas

KW - Ultrasonography

UR - https://www.scopus.com/pages/publications/37049026038

U2 - 10.6004/jnccn.2007.0085

DO - 10.6004/jnccn.2007.0085

M3 - Review article

C2 - 18053426

AN - SCOPUS:37049026038

SN - 1540-1405

VL - 5

SP - 998

EP - 1033

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Pancreatic adenocarcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this